OBJECTIVE: To assess the association between vaginal douching and sexually transmitted infections (STI) among a group of female sex workers (FSWs) in Nairobi, Kenya. METHODS: This study was part of a randomised, placebo controlled trial of monthly prophylaxis with 1 g of azithromycin to prevent STIs and HIV infection in a cohort of Nairobi FSWs. Consenting women were administered a questionnaire and screened for STIs. RESULTS: The seroprevalence of HIV-1 among 543 FSWs screened was 30%. HIV infection was significantly associated with bacterial vaginosis (BV), trichomoniasis, gonorrhoea, and the presence of a genital ulcer. Regular douching was reported by 72% of the women, of whom the majority inserted fluids in the vagina, generally after each sexual intercourse. Water with soap was the fluid most often used (81%), followed by salty water (18%), water alone (9%), and a commercial antiseptic (5%). Douching in general and douching with soap and water were significantly associated with bacterial vaginosis (p = 0.05 and p = 0.04 respectively). There was a significant trend for increased frequency of douching and higher prevalence of BV. There was no direct relation observed between douching and risk for HIV infection or other STIs. CONCLUSION: The widespread habit of douching among African female sex workers was confirmed. The association between vaginal douching and BV is of concern, given the increased risk of HIV infection with BV, which has now been shown in several studies. It is unclear why we could not demonstrate a direct association between douching and HIV infection. Further research is required to better understand the complex relation between douching, risk for bacterial vaginosis, and risk for HIV and other STIs.
RCT Entities:
OBJECTIVE: To assess the association between vaginal douching and sexually transmitted infections (STI) among a group of female sex workers (FSWs) in Nairobi, Kenya. METHODS: This study was part of a randomised, placebo controlled trial of monthly prophylaxis with 1 g of azithromycin to prevent STIs and HIV infection in a cohort of Nairobi FSWs. Consenting women were administered a questionnaire and screened for STIs. RESULTS: The seroprevalence of HIV-1 among 543 FSWs screened was 30%. HIV infection was significantly associated with bacterial vaginosis (BV), trichomoniasis, gonorrhoea, and the presence of a genital ulcer. Regular douching was reported by 72% of the women, of whom the majority inserted fluids in the vagina, generally after each sexual intercourse. Water with soap was the fluid most often used (81%), followed by salty water (18%), water alone (9%), and a commercial antiseptic (5%). Douching in general and douching with soap and water were significantly associated with bacterial vaginosis (p = 0.05 and p = 0.04 respectively). There was a significant trend for increased frequency of douching and higher prevalence of BV. There was no direct relation observed between douching and risk for HIV infection or other STIs. CONCLUSION: The widespread habit of douching among African female sex workers was confirmed. The association between vaginal douching and BV is of concern, given the increased risk of HIV infection with BV, which has now been shown in several studies. It is unclear why we could not demonstrate a direct association between douching and HIV infection. Further research is required to better understand the complex relation between douching, risk for bacterial vaginosis, and risk for HIV and other STIs.
Authors: K Fonck; R Kaul; J Kimani; F Keli; K S MacDonald; A R Ronald; F A Plummer; P Kirui; J J Bwayo; E N Ngugi; S Moses; M Temmerman Journal: Int J STD AIDS Date: 2000-12 Impact factor: 1.359
Authors: P Wølner-Hanssen; D A Eschenbach; J Paavonen; C E Stevens; N B Kiviat; C Critchlow; T DeRouen; L Koutsky; K K Holmes Journal: JAMA Date: 1990-04-11 Impact factor: 56.272
Authors: J M Mann; N Nzilambi; P Piot; N Bosenge; M Kalala; H Francis; R C Colebunders; P K Azila; J W Curran; T C Quinn Journal: AIDS Date: 1988-08 Impact factor: 4.177
Authors: J H van De Wijgert; P R Mason; L Gwanzura; M T Mbizvo; Z M Chirenje; V Iliff; S Shiboski; N S Padian Journal: J Infect Dis Date: 2000-02 Impact factor: 5.226
Authors: Roberta B Ness; Sharon Hillier; Holly E Richter; David E Soper; Carol Stamm; Debra C Bass; Richard L Sweet; Peter Rice Journal: J Natl Med Assoc Date: 2003-03 Impact factor: 1.798
Authors: Maria L Alcaide; Violeta J Rodriguez; Megan R Brown; Suresh Pallikkuth; Kristopher Arheart; Octavio Martinez; Margaret Roach; Raina N Fichorova; Deborah L Jones; Savita Pahwa; Margaret A Fischl Journal: AIDS Res Hum Retroviruses Date: 2017-01-03 Impact factor: 2.205
Authors: R J Diclemente; A M Young; J L Painter; G M Wingood; E Rose; J M Sales Journal: J Pediatr Adolesc Gynecol Date: 2011-11-03 Impact factor: 1.814
Authors: Andrew Vallely; Ian R Hambleton; Stella Kasindi; Louise Knight; Suzanna C Francis; Tobias Chirwa; Dean Everett; Charles Shagi; Claire Cook; Celia Barberousse; Deborah Watson-Jones; John Changalucha; David Ross; Richard J Hayes Journal: PLoS One Date: 2010-05-14 Impact factor: 3.240
Authors: Rebecca M Brotman; Khalil G Ghanem; Mark A Klebanoff; Taha E Taha; Daniel O Scharfstein; Jonathan M Zenilman Journal: Am J Obstet Gynecol Date: 2008-03-04 Impact factor: 8.661